DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Ind-Swift Laboratories Limited — Investor Presentation

NSE 18 min ago·17 Aug 2026, 9:12 am

Ind-Swift Laboratories

Ind-Swift Laboratories Limited has informed stock exchanges about the release of its upcoming investor presentation. This disclosure signals that the company is preparing to update the market on its financial performance and strategic outlook.

For investors, this update is a key opportunity to gain clarity on the company's current trajectory. It provides a platform for management to discuss operational metrics, future growth plans, and address any market concerns directly.

Investors should closely watch the presentation for revised guidance, commentary on demand trends, and updates on capital allocation. This information will be crucial for assessing the company's medium-term prospects.